AKT1 and cancer: Similar pathways of juglanin anti-cancer impact were observed in other studies, i.e., via JNK, p38, PI3K and AKT signaling in a mouse model of UVB-induced skin cancer [81] and JNK signaling in the breast tumor-transplanted mouse model [77].